Literature DB >> 18481996

Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation.

Sarah A Cumming1, Thanaporn Cheun-Im, Stephen G Milligan, Sheila V Graham.   

Abstract

HPV16 (human papillomavirus type 16) is a 7.9 kb double-stranded DNA virus that infects anogenital mucosal epithelia. In some rare cases, in women, infection can progress to cervical cancer. HPV16 gene expression is regulated through use of multiple promoters and alternative splicing and polyadenylation. The virus genome can be divided into an early and a late coding region. The late coding region contains the L1 and L2 genes. These encode the virus capsid proteins L1 and L2; protein expression is confined to the upper epithelial layers and is regulated post-transcriptionally in response to epithelial differentiation. A 79 nt RNA regulatory element, the LRE (late regulatory element), involved in this regulation is sited at the 3'-end of the L1 gene and extends into the late 3'-UTR (3'-untranslated region). This element represses late gene expression in differentiated epithelial cells and may activate it in differentiated cells. The present paper describes our current knowledge of LRE RNA-protein interaction and their possible functions.

Entities:  

Mesh:

Year:  2008        PMID: 18481996      PMCID: PMC2779515          DOI: 10.1042/BST0360522

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  14 in total

1.  The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure.

Authors:  B I Klasens; M Thiesen; A Virtanen; B Berkhout
Journal:  Nucleic Acids Res       Date:  1999-01-15       Impact factor: 16.971

2.  Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo.

Authors:  I M Kennedy; J K Haddow; J B Clements
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Properties of a non-tumorigenic human cervical keratinocyte cell line.

Authors:  M A Stanley; H M Browne; M Appleby; A C Minson
Journal:  Int J Cancer       Date:  1989-04-15       Impact factor: 7.396

4.  The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels.

Authors:  M D Koffa; S V Graham; Y Takagaki; J L Manley; J B Clements
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

5.  An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels.

Authors:  P A Furth; C C Baker
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions.

Authors:  P A Furth; W T Choe; J H Rex; J C Byrne; C C Baker
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

Review 7.  Pathogenesis of human papillomaviruses in differentiating epithelia.

Authors:  Michelle S Longworth; Laimonis A Laimins
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

8.  SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells.

Authors:  Maria G McPhillips; Thanaporn Veerapraditsin; Sarah A Cumming; Dimitra Karali; Steven G Milligan; Winifred Boner; Iain M Morgan; Sheila V Graham
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells.

Authors:  Steven G Milligan; Thanaporn Veerapraditsin; Boolang Ahamet; Sarah Mole; Sheila V Graham
Journal:  Virology       Date:  2006-11-13       Impact factor: 3.616

10.  The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element.

Authors:  Thanaporn Cheunim; Jingxin Zhang; Steven G Milligan; Maria G McPhillips; Sheila V Graham
Journal:  Virus Res       Date:  2007-10-24       Impact factor: 3.303

View more
  6 in total

1.  Functional analysis of HPV-like particle-activated Langerhans cells in vitro.

Authors:  Lisa Yan; Andrew W Woodham; Diane M Da Silva; W Martin Kast
Journal:  Methods Mol Biol       Date:  2015

2.  Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro.

Authors:  Andrew W Woodham; Adam B Raff; Diane M Da Silva; W Martin Kast
Journal:  Methods Mol Biol       Date:  2015

3.  Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.

Authors:  Andrew W Woodham; Adam B Raff; Laura M Raff; Diane M Da Silva; Lisa Yan; Joseph G Skeate; Michael K Wong; Yvonne G Lin; W Martin Kast
Journal:  J Immunol       Date:  2014-04-09       Impact factor: 5.422

4.  Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variations.

Authors:  Paramita Mandal; Bornali Bhattacharjee; Damayanti Das Ghosh; Nidhu Ranjan Mondal; Rahul Roy Chowdhury; Sudipta Roy; Sharmila Sengupta
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

5.  The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.

Authors:  Andrew W Woodham; Diane M Da Silva; Joseph G Skeate; Adam B Raff; Mark R Ambroso; Heike E Brand; J Mario Isas; Ralf Langen; W Martin Kast
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

6.  Metagenomic assay for identification of microbial pathogens in tumor tissues.

Authors:  Don A Baldwin; Michael Feldman; James C Alwine; Erle S Robertson
Journal:  mBio       Date:  2014-09-16       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.